Table 1 Experiment 1 participant characteristics

Age (years)

30

18.9–40.7

30.8 (6.3)

25

18.0–44.7

30.1 (6.9)

0.55

0.59

CGG

27

20–44

30.0 (4.6)

25

55–156

96.1 (25.3)

-12.9

<0.001

mRNA

25

0.97–1.77

1.40 (0.23)

24

1.85–4.89

2.76 (0.77)

-8.24

<0.001

FSIQ

25

85–148

118 (15)

24

79–143

114 (15)

0.91

0.37

Age (years)

31

20.5–40.8

30.6 (6.5)

43

15.4–42.8

33.3 (5.9)

-2.59

0.01*

CGG

29

28–47

31.2 (3.7)

43

67–178

95.6 (19.9)

-20.69

<0.001

mRNA

28

0.9–1.98

1.41 (0.27)

43

1.55–4.62

2.39 (0.59)

-9.42

<0.001

FSIQ

23

89–136

112 (13)

37

97–148

117 (13)

-1.31

0.20

Age (years)

16

7.6–12.8

10.5 (1.8)

21

8.4–13.1

10.4 (1.4)

0.10

0.92

CGG

15

20–37

29.1 (4.7)

20

55–157

87.1 (30.7)

-8.31

<0.001

mRNA

15

1.06–1.8

1.37 (0.24)

19

1.6–5.05

2.49 (0.88)

-5.31

<0.001

FSIQ

12

101–139

120 (11)

11

73–113

97 (12)

4.72

<0.001

Age (years)

13

8.0–12.4

10.0 (1.6)

15

7.8–14.3

11.1 (1.9)

-2.40

0.02*

CGG

10

25–34

30.5 (2.6)

15

57–147

98.1 (32.3)

-8.06

<0.001

mRNA

7

1.02–1.8

1.39 (0.25)

14

1.28–5.19

2.61 (1.16)

-3.75

0.002**

FSIQ

12

90–129

110 (12)

14

75–139

109 (19)

0.17

0.87